PDT	Photodynamic therapy
TME	Tumor microenvironment
ICD	Immunogenic cell death
PS	Photosensitizer
ROS	Reactive oxygen species
EPR	Enhanced permeability and retention
DAMPs	Damage-associated molecular patterns
ICIs	Immune checkpoint inhibitors
DC	Dendritic cell
NIR-PIT	Near-infrared photoimmunotherapy
COX-2	Cyclooxygenase-2
PACT	Photoactivated chemotherapy
HpD	Hematoporphyrin derivatives
Ce6	Chlorin e6
HPPH	2-[1-hexyloxyethyl]-2-devinyl pyro pheophorbide-a
NIR	Near-infrared
ICG	Indocyanine green
HCC	Hepatocellular carcinoma
PPa	Pheophorbide-a
ZnPc	Zinc phthalocyanine
VTP	Vascular-targeted photodynamic
NPs	Nanoparticles
LDL	Low-density lipoprotein
iPDT	Interstitial PDT
DNA	Deoxyribonucleic acid
BC	Breast cancer
MB	Methylene blue
DOX	Doxorubicin
5-ALA/ALA	5-aminolevulinic acid
SCLC	Small-cell lung cancer
AlPc	Aluminum phthalocyanine
Hp	Hematoporphyrin
PpIX	Protoporphyrin IX
PI3K/AKT	Phosphoinositide 3-kinase/Protein kinase B signaling pathway
PCI	Photochemical internalization
NSCLC	Non-small cell lung cancer
ECOG	Eastern Cooperative Oncology Group
ECA	External carotid artery
CT	Computed tomography (or Chemotherapy in some contexts)
mFOLFIRINOX	Modified FOLFIRINOX (5-fluorouracil, leucovorin, irinotecan, and oxaliplatin)
CSCs	Cancer stem cells
OXPHOS	Oxidative phosphorylation
PDP	Photodynamic priming
ECM	Extracellular matrix
IFP	Interstitial fluid pressure
GSH	Glutathione
MDSC	Myeloid-derived suppressor cell
PGE2	Prostaglandin E2
NSAIDs	Non-steroidal anti-inflammatory drugs
VEGF	Vascular Endothelial Growth Factor
AIE	Aggregation-induced emission
TAAs	Tumor-associated antigens
ATP	Adenosine triphosphate
CRT	Calreticulin
CTL	Cytotoxic T lymphocyte
CTLA-4	Cytotoxic T-lymphocyte-associated protein 4
EITC	Eosin-5-isothiocyanate
UCNPs	Upconversion nanoparticles
UCNP-Ce6-R837	Ce6 and imiquimod (R837) co-loaded upconversion nanoparticles (UCNPs)
NATNgel	NIR fluorescent dye-loaded activatable theranostic nanogel
TNF-α	Tumor necrosis factor-alpha
PD-L1	Programmed death-ligand 1
HIF-1α	Hypoxia-inducible factor 1-alpha
EGFR	Epidermal growth factor receptor
HER2	Human epidermal growth factor receptor 2
HNSCC	Head and neck squamous cell carcinomas
PIT	Photoimmunotherapy
CPS	Combined Positive Score
PDT-DC	Photodynamically sensitized dendritic cell
ER	Endoplasmic reticulum
PNPs	Polymeric nanoparticles
NLCs	Nanostructured lipid carriers
AuNPs	Gold nanoparticles
PDA	Polydopamine
pNALs	Photoactivable nanoliposomes
Combo-NP	Biodegradable fluorescent NIR-II pseudoconjugated polymer nanoparticle
NIR-II	Near-infrared II
CA4P	Combretastatin A4 phosphate
ICG-Lipo-C&D	Liposomally formulated indocyanine green derivative (ICG-Lipo) encapsulating carboplatin and docetaxel (C&D)
GA/RGD-DOX/ICG-Lips	Glycyrrhetinic acid (GA)/arginine-glycine-aspartate (RGD)-targeted and doxorubicin (DOX)/indocyanine green (ICG)-loaded Liposomes
GMP	Good Manufacturing Practice
DLI	Drug-Light Interval
TIL	Tumor-infiltrating lymphocytes
TMB	Tumor mutational burden
TKI	Tyrosine kinase inhibitor
PK	Pharmacokinetics
TNBC	Triple-negative breast cancer
PDAC	Pancreatic ductal adenocarcinoma
DMBA	7,12-dimethylbenz[a] anthracene
PCDD NPs	Platelet membrane-coated nanoparticles
QbD	Quality by design